Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Biosino Bio-Technology and Science Days Inventory?
Biosino Bio-Technology and ScienceHKSE:08247 -2.62%37 Days Inventory is 155.09 as of Dec. 2025, which is 44% above its 10-year median of 107.80. GuruFocus rates HKSE:08247 with a GF Score™ of 37/100 and a GF Value™ of HK$0.44 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 176 Medical Diagnostics & Research companies, Biosino Bio-Technology and Science ranks worse than 81.25% on this metric.
HKSE:08247'
s Days Inventory Range Over the Past 10 Years
Min: 92.93 Med: 107.8 Max: 156.81
Current: 156.81
During the past 13 years, Biosino Bio-Technology and Science's highest Days Inventory was 156.81. The lowest was 92.93. And the median was 107.80.
HKSE:08247's Days Inventory is ranked worse than 81.25% of 176
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.715
vs HKSE:08247: 156.81
Inventory Turnover measures how fast the company turns over its inventory within a year.
Biosino Bio-Technology and Science's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.18.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biosino Bio-Technology and Science's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.53.
Biosino Bio-Technology and Science (HKSE:08247) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Biosino Bio-Technology and Science's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Biosino Bio-Technology and Science's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Biosino Bio-Technology and Science Days Inventory Related Terms
Biosino Bio-Technology and Science Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biosino Bio-Technology and Science Days Inventory Chart
HKSE:08247 vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Biosino Bio-Technology and Science's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biosino Bio-Technology and Science Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Biosino Bio-Technology and Science's Days Inventory distribution charts can be found below:
* The bar in red indicates where Biosino Bio-Technology and Science's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biosino Bio-Technology and Science (HKSE:08247) has a Days Inventory of 155.09 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Biosino Bio-Technology and Science and its competitors. This is 44% above median its historical median of 107.80. Over the past decade, Biosino Bio-Technology and Science's Days Inventory has ranged from 92.93 to 156.81. According to the industry distribution chart, Biosino Bio-Technology and Science ranks #143 out of 176 companies in the Medical Diagnostics & Research industry, placing it in the top 81.2%.
Is Biosino Bio-Technology and Science's Days Inventory too high?
Biosino Bio-Technology and Science's current Days Inventory of 155.09 is 44% above median its 10-year median of 107.80. Over the past 10 years, this metric has ranged from a low of 92.93 to a high of 156.81. The Medical Diagnostics & Research industry median Days Inventory is 67.72. Biosino Bio-Technology and Science's value of 155.09 is 129% above this industry median. Based on the distribution chart, Biosino Bio-Technology and Science ranks #143 out of 176 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Biosino Bio-Technology and Science has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biosino Bio-Technology and Science's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Biosino Bio-Technology and Science ranks #143 out of 176 companies for Days Inventory. This places Biosino Bio-Technology and Science in the lower half of its industry. The industry median Days Inventory is 67.72. Biosino Bio-Technology and Science's value of 155.09 is 129% above this benchmark. Historically, Biosino Bio-Technology and Science's own Days Inventory has ranged from 92.93 to 156.81 over the past decade. While the company's 10-year median is 107.80 vs. the industry median of 67.72, Biosino Bio-Technology and Science has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 67.72, based on 176 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biosino Bio-Technology and Science's current Days Inventory of 155.09 is 129% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Biosino Bio-Technology and Science and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 67.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biosino Bio-Technology and Science's current Days Inventory is 155.09, which is 44% above median its own 10-year median of 107.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosino Bio-Technology and Science stock overvalued right now?
Based on GuruFocus' analysis, Biosino Bio-Technology and Science (HKSE:08247) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.44, compared to a current price of HK$3.17 — trading 619.3% above its estimated fair value. The current Days Inventory is 155.09, which is 44% above median its 10-year median of 107.80 and 129% above the Medical Diagnostics & Research industry median of 67.72. Biosino Bio-Technology and Science's overall GF Score™ is 37/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Biosino Bio-Technology and Science (HKSE:08247), the current Days Inventory is 155.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biosino Bio-Technology and Science (HKSE:08247) Overvalued in 2026?
Based on GuruFocus' analysis, Biosino Bio-Technology and Science stock appears to be overvalued.
The current stock price of HK$3.17 is trading 619.3% above its estimated GF Value™ of HK$0.44.
GuruFocus considers Biosino Bio-Technology and Science to be Significantly Overvalued.
Key valuation signals for HKSE:08247:
Days Inventory: 155.09 (44% above median its 10-year median of 107.80)
GF Value™: HK$0.44 vs. price of HK$3.17 (619.3% above fair value)
Industry Position: 129% above the Medical Diagnostics & Research median (#143 of 176)
No single metric tells the full story. See the HKSE:08247 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of IVD reagent products. The company operates in a single segment, the in-vitro diagnostic products segment, which manufactures, sells, and distributes a variety of mono/double diagnostic products. Geographically, it generates the majority of the revenue from Mainland China.
37GF Score
Get the complete analysis for HKSE:08247
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08247 has been successfully added to your 
